The Medicare GLP-1 Bridge programme
Direct answer
What you need to know
Evidence strength: StrongThe Bridge makes selected weight-management medicines available for $50 per month to eligible adults with Medicare drug coverage, from 1 July 2026 through 31 December 2027. Your Part D plan does not need to opt in. Eligibility, diagnosis and the exact formulation determine which payment route applies.
Key takeaways
- Three BMI tiers have different condition requirements.
- The pharmacy claim comes before the Bridge prior-authorisation request.
- Some non-weight-loss indications belong under ordinary Part D.
- The copay does not reduce your Part D deductible or count toward its annual limit.
Important limitation: This summary does not determine individual eligibility. CMS terms and clinical documentation control the decision.
Next action: Take your diagnosis, BMI at treatment initiation and Medicare drug-plan details to your prescriber. Use the checklist below.
Primary sources: CMS, Medicare.gov, CMS
Eligibility checklist: which BMI tier applies?
You must be at least 18 and have eligible Medicare prescription-drug coverage. CMS includes standalone prescription drug plans and Medicare Advantage coordinated-care plans with drug coverage; its provider guidance details other eligible and excluded plan types. Nutrition and physical activity must be prescribed alongside treatment.
| BMI | Additional qualifying condition |
|---|---|
| 35 or higher | No additional condition in this BMI tier. |
| 30 or higher | Heart failure with preserved ejection fraction; uncontrolled hypertension; or chronic kidney disease stage 3a or higher. |
| 27 or higher | Prediabetes; previous myocardial infarction (heart attack); previous stroke; or symptomatic peripheral artery disease. |
For the hypertension criterion, CMS specifies systolic pressure above 140 or diastolic pressure above 90 despite two antihypertensive medicines. The BMI 27 tier is not a general “any weight-related condition” rule.
Bridge or ordinary Part D?
If the prescribed use can be covered under ordinary Part D, that is the applicable pathway rather than the Bridge. CMS names type 2 diabetes, moderate-to-severe obstructive sleep apnoea, and noncirrhotic MASH with moderate-to-advanced fibrosis as examples. The diagnosis and product indication matter; the Bridge is not a way to bypass a Part D coverage decision for those uses.
Covered medicines and devices
- Wegovy (injection or tablet)
- Zepbound (KwikPen only)
- Foundayo (tablet)
Excluded: Zepbound single-dose pens and Zepbound vials. A prescription for Zepbound alone does not establish that the covered device has been prescribed. Check the formulation with the pharmacy.
How to apply and obtain prior authorisation
- Your prescriber checks eligibility and sends a prescription for a covered formulation to the pharmacy.
- The pharmacy submits a claim to the Bridge processor and requests prior authorisation from the prescriber.
- The prescriber supplies the required clinical documentation electronically or using the official fax form.
Submitting prior authorisation before the pharmacy claim can produce a “patient not found” error. A Part D denial is not a prerequisite. The CMS provider page and official prior-authorisation form are the source for the current process, including what to do when a pharmacy request has not arrived.
What the $50 covers — and what happens in 2027
- This operates outside Part D payment. A condition for which the drug can be covered under ordinary Part D uses that route instead.
- The $50 does not count toward your Part D deductible or annual out-of-pocket limit.
- Part D low-income subsidies cannot reduce the Bridge copay.
- The programme runs through 31 December 2027. CMS says BALANCE will not launch in 2027; a successor is not guaranteed.
Other expenses may remain, including separately supplied needles. Compare the other ways to pay for treatment if you do not qualify.
Frequently asked questions
Does my Part D plan have to opt in?
No. CMS runs the Bridge outside the ordinary Part D payment process. You still need eligible Medicare drug coverage and must meet the programme’s clinical and prior-authorisation criteria.
Where is the Medicare GLP-1 Bridge application form?
There is no patient self-enrolment form that replaces a prescription. Your prescriber sends the prescription to the pharmacy; the pharmacy submits a Bridge claim and requests prior authorisation. The CMS provider page linked below supplies the official fax form, although CMS encourages electronic submission.
When does the Medicare GLP-1 Bridge end?
The published end date is 31 December 2027. CMS says the BALANCE model will not launch in 2027. Do not assume coverage automatically continues afterward.
Does the $50 count toward my Medicare out-of-pocket maximum?
No. Bridge payments do not count toward the Part D deductible or annual out-of-pocket limit. Extra Help does not reduce the Bridge copay.
Correction, 22 September 2026: an earlier version incorrectly required plan opt-in and oversimplified the BMI criteria. The public corrections log records the changes.
Sources
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
- Medicare GLP-1 Bridge — information for providersCMSSupports: Clinical criteria, formulations and prior-authorisation sequence. Checked 22 September 2026.
- Weight-loss drugsMedicare.govSupports: Patient eligibility, $50 copay and the ordinary Part D distinction.
- Medicare GLP-1 BridgeCMSSupports: Operation outside Part D, no sponsor opt-in, July 2026–December 2027 dates and BALANCE timing.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.